Digital
BIO - Day 2

BIO - Day 2

On Wednesday, the day begins with keynote Dr Robert Califf, current and former FDA Commissioner.

Oncology
ASCO 2023

ASCO 2023 – Arun Krishna

With a 51% reduction in deaths, AstraZeneca’s ADAURA trial was one of the breakout stories of this year’s ASCO.

Featured Content

Oncology
ASCO 2023

ASCO 2023 – Arun Krishna

With a 51% reduction in deaths, AstraZeneca’s ADAURA trial was one of the breakout stories of this year’s ASCO.

Sales & Marketing
Coaching Never Sleeps
Sponsored

Coaching Never Sleeps

Coaching has developed into one of the most powerful tools in a fast-changing pharmaceutical sector.

Newsletters and Deep Dive
digital magazine

Latest News

Views & Analysis

Digital
BIO - Day 2

BIO - Day 2

On Wednesday, the day begins with keynote Dr Robert Califf, current and former FDA Commissioner.

Digital
BIO - Day 1

BIO - Day 1

Tuesday is the first full day at BIO and it kicks off with Katie Couric, who will be interviewed by BIO CEO Rachel King in her role as a cancer advocate.

Digital
BIO event

BIO 2023

BIO is back in Boston and the four-day conference is welcoming famed news anchor Katie Couric and FDA Commissioner Dr Robert Califf as its top keynote speakers.

Deep Dive

Market Access
Market Access 2023

Market Access 2023

Getting the right treatment, to the right patient, at the right time is the backbone of market access.

R&D
Around the world in pharma events

Around the world in pharma events

Stay up to date with key industry meetings and conferences in 2023 Americas FT US Pharma & Biotech Summit 16-17-May New York, US

White Papers & Webinar

Sales & Marketing
Coaching Never Sleeps
Sponsored

Coaching Never Sleeps

Coaching has developed into one of the most powerful tools in a fast-changing pharmaceutical sector.

Podcasts & Video

Oncology
ASCO 2023

ASCO 2023 – Arun Krishna

With a 51% reduction in deaths, AstraZeneca’s ADAURA trial was one of the breakout stories of this year’s ASCO.

R&D
Health Innovators Jennifer Schranz

Health Innovators – Jennifer Schranz

In the rare and ultra-rare disease space, the paucity of both data and patients makes everything about research and development more complicated.

Digital
pharmaphorum podcast episode 87

AI in drug development: A reality check

In this episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock catches up with Adityo Prakash, CEO of Verseon, to shed some light on what the potential of AI in drug discovery

Partner Content

Oncology
mRNA Cancer Vaccine Summit 2023
Partner Content

mRNA Cancer Vaccine Summit 2023

The mRNA Cancer Vaccine Summit 2023 comes to Boston as the community is on the cusp of something truly exciting.

R&D
Welcome to the 5th TIL Therapies Summit!
Partner Content

Welcome to the 5th TIL Therapies Summit!

The first commercial TIL therapy is brewing at Iovance, along with various clinical readouts which are set to come to fruition in 2023, along with the 5th TIL Therapies Summit whic

R&D
5th Exosome Based Therapeutic Development Summit
Partner Content

5th Exosome Based Therapeutic Development Summit

The 5th Exosome Based Therapeutic Development Summit returns with a refreshed program, with data-driven insights from those pioneering the field who are dedicated to the clinical translatio

Oncology
8th CAR-TCR Summit
Partner Content

8th CAR-TCR Summit

The 8th CAR-TCR Summit is returning to Boston as the industry’s trusted, definitive, end-to-end forum for the global network of autologous and allogeneic cell therapy drug develope